Zurich Cantonal Bank’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
2023
Q1
$407K Buy
2022
Q4
$292K Sell
2022
Q3
$171K Buy
2022
Q2
$63K Sell
2022
Q1
$86K Buy